Physicians, pharmacists and take-home naloxone: What practices? The SINFONI study

M. DUVAL ; A. AQUIZERATE ; E. JAULIN ; M. ROUSSELET ; E. KUHN ; A. GUILLEMINOT ; I. NICOLLEAU ; S. PELE ; T. HERAULT ; P. ARTARIT ; E. SOULIDOU-JACQUES ; E. J. LAFORGUE ; C. VICTORRI-VIGNEAU | 2024
Dans Therapies (Vol.79, n°6, Novembre-Décembre 2024) Article : Périodique

Objective: For several years, both the French Addictovigilance Network and French health authorities have consistently emphasized the need to provide opioid users with take-home naloxone (THN), the specific antidote for opioid overdoses. In Marc[...]

Plus d'info

Ajouter à la sélection

Lien externe

Screening for alcohol use in primary care: assessing French general practitioner practices

T. BARRÉ ; V. DI BEO ; P. ROUX ; A. MOURAD ; P. VERGER ; L. FRESSARD ; T. HERAULT ; J. F. BUYCK ; F. BECK ; P. CARRIERI | 2023
Dans Alcohol and Alcoholism (Vol.58, n°6, November 2023) Article : Périodique

Alcohol use is a leading risk factor for premature death and disability. To tackle this issue, more systematic and accurate screening for at-risk consumption is needed in healthcare systems, especially by general practitioners (GPs). We assessed[...]

Plus d'info

Ajouter à la sélection

Lien externe

Screening for tobacco and cannabis use by general practitioners: A French nationwide representative survey

T. BARRÉ ; V. DI BEO ; A. MOURAD ; P. CARRIERI ; G. MARADAN ; L. FRESSARD ; T. HERAULT ; J. F. BUYCK ; P. VERGER ; F. BECK | 2024
Dans International Journal of Mental Health and Addiction (Online first 26/04/2024, 2024) Article : Périodique

Screening is a crucial step in the cascade of care for people who smoke tobacco or cannabis. In France, general practitioners (GPs) are considered a pillar of tobacco control, and under National Authority of Health guidelines, they are expected [...]

Plus d'info

Ajouter à la sélection

Lien externe